Delavirdine

Contraindicated

Delavirdine Dihydroergotamine Injection DHE-45® Injection Increased dihydroergotamine exposure and an increased risk of ergot toxicity (vasospastic ischemia) Details Delavirdine Dihydroergotamine Nasal Spray Migranal Increased dihydroergotamine exposure and an increased risk of ergot toxicity (vasospastic ischemia) Details Delavirdine Maraviroc Selzentry Increased maraviroc concentrations Details Delavirdine Midazolam Nasal Spray Nayzilam Increased midazolam concentrations Details Delavirdine Midazolam Injection Nayzilam Increased midazolam concentrations Details Delavirdine Nimodipine Nimotop Increased serum nimodipine concentrations Details

Major

Delavirdine Acetaminophen And Codeine Capital® & Codeine Explained Increased codeine and morphine exposure Details Delavirdine Omeprazole Gastrobim Explained Reduced serum delavirdine levels Details Delavirdine Buprenorphine Belbuca Explained Increased buprenorphine exposure and an increased risk of buprenorphine-related adverse events Details Delavirdine Colchicine Colcrys Explained Increased colchicine exposure and an increased risk of colchicine-related toxicity Details Delavirdine Simvastatin Flolipid Explained An increased risk of myopathy or rhabdomyolysis Details Delavirdine Bedaquiline Sirturo Increased bedaquiline exposure Details Delavirdine Brentuximab Vedotin Injection Adcetris Increased exposure to active entity of brentuximab vedotin Details Delavirdine Budesonide Entocort Increased budesonide exposure Details Delavirdine Budesonide Nasal Spray Rhinocort Increased budesonide exposure Details Delavirdine Budesonide Oral Inhalation Pulmicort Increased budesonide exposure Details Delavirdine Cabazitaxel Injection Jevtana Increased cabazitaxel exposure Details Delavirdine Cabotegravir Apretude Loss of virologic response and possible development of viral resistance Details Delavirdine Cyclosporine Injection Atopica Increased cycloSPORINE exposure Details Delavirdine Cyclosporine Ophthalmic Cequa Increased cycloSPORINE exposure Details Delavirdine Doxorubicin Adriamycin Increased doxorubicin exposure and an increased risk of doxorubicin-related adverse reactions Details Delavirdine Famotidine Calmicid Reduced serum delavirdine levels Details Delavirdine Famotidine Injection Calmicid Reduced serum delavirdine levels Details Delavirdine Fentanyl Transdermal Patch Duragesic® Increased fentaNYL exposure and an increased risk of prolonged opioid effects Details Delavirdine Finerenone Kerendia Increased finerenone exposure and an increased risk of finerenone-related adverse effects Details Delavirdine Flecainide Tambocor® Increased flecainide levels Details Delavirdine Ifosfamide Injection Ifex Decreased ifosfamide effectiveness Details Delavirdine Ketoconazole Topical Extina® Foam Increased serum concentrations of delavirdine and/or ketoconazole Details Delavirdine Lansoprazole Prevacid Reduced serum delavirdine levels Details Delavirdine Loperamide Diamode Increased loperamide exposure and an increased risk of loperamide-related adverse reactions Details Delavirdine Lovastatin Altocor® An increased risk of myopathy or rhabdomyolysis Details Delavirdine Lurasidone Latuda Increased lurasidone exposure Details Delavirdine Methylergonovine Methergine Increased methylergonovine exposure Details Delavirdine Nevirapine Viramune Altered exposure of delavirdine, nevirapine or both Details Delavirdine Nifedipine Adalat® Increased NIFEdipine exposure Details Delavirdine Nizatidine Axid® Reduced serum delavirdine levels Details Delavirdine Olaparib Lynparza Increased olaparib exposure Details

Moderate

Delavirdine Atorvastatin Atorvaliq An increased risk of myopathy or rhabdomyolysis Details Delavirdine Alfuzosin UroXatral An increase in alfuzosin exposure Details Delavirdine Dexamethasone Injection Decadron Reduced delavirdine effectiveness Details